Johan  Jarl

Dr. Johan Jarl

Health Economics Unit, Department of Clinical Science (Malmö), Lund University, Lund, Sweden
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2011 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Gawain HeckleyGawain Heckley
Gawain Heckley
Johan  JarlJohan Jarl
Johan Jarl
BABenedict O Asamoah
Benedict O Asamoah
UGUlf-Göran Gerdtham
Ulf-Göran Gerdtham
It is well established that drinking alcohol raises the risk of liver cancer (hepatocellular carcinoma). However, it has not been sufficiently established as to whether or not drinking cessation subsequently reduces the risk of liver cancer and if it does reduce the risk how long it takes for this heightened risk to fall to that of never drinkers. This question is important for effective policy design and evaluation, to establish causality and for motivational treatments.

28 November 2007 in The European Journal of Health Economics
Verified
Journal Article
Closed access
PDF file
Johan  JarlJohan Jarl
Johan Jarl
PJPia Johansson
Pia Johansson
AEAntonina Eriksson
Antonina Eriksson
MEMimmi Eriksson
Mimmi Eriksson
UGUlf-Göran Gerdtham
Ulf-Göran Gerdtham
RRRobin Room
Robin Room

7 August 2017 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
Johan  JarlJohan Jarl
Johan Jarl
PDPeter Desatnik
Peter Desatnik
UHUlrika Peetz Hansson
Ulrika Peetz Hansson
KPKarl Göran Prütz
Karl Göran Prütz
UGUlf-Göran Gerdtham
Ulf-Göran Gerdtham
The health care costs of kidney transplantation and dialysis are generally unknown. This study estimates the Swedish health care costs of kidney transplantation and dialysis over 10 years from a health care perspective. A before–after design was used, in which the patients served as their own controls. Health care costs the year before transplantation were assumed to continue in the absence of a transplant and the cost savings was therefore calculated as the difference between the expected costs and the actual costs during the 10-year follow-up period. Factors associated with the size of the cost savings were studied using ordinary least-squares regression. Altogether 66–79% of the expected health care costs over 10 years were avoided through kidney transplantation, resulting in a cost savings of €380 000 (2012 price-year) per patient. Savings were the highest for successful transplantations, but on average the treatment was cost-saving also for patients who returned to dialysis. No gender or age differences could be found, with the exception of a higher cost of transplantation for children and a generally higher cost for younger compared with older patients on dialysis. A negative association was also found between age at the time of transplantation and the size of the cost savings for the younger part of the sample. Kidney transplantations have led to substantial cost savings for the Swedish health care system. An increase in donated kidneys has the potential to further reduce the cost of renal replacement therapy.

1 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAliasghar Ahmad Kiadaliri
Aliasghar Ahmad Kiadaliri
Johan  JarlJohan Jarl
Johan Jarl
GGGeorgios Gavriilidis
Georgios Gavriilidis
UGUlf-Göran Gerdtham
Ulf-Göran Gerdtham
To evaluate the effect of alcohol cessation on the risk of developing laryngeal and pharyngeal cancers, combining available evidence in the scientific literature in a meta-analysis. A systematic literature review was conducted, and a meta-analysis was applied on the retrieved studies. The generalised least squares method was used to estimate the trend from dose-response data to assess changes in the risks of laryngeal and pharyngeal cancers after drinking cessation. A total of 9 case-control studies were included in the meta-analysis (4 and 8 estimates for laryngeal and pharyngeal cancers, respectively). On average, alcohol drinking cessation was associated with a 2% yearly reduction in the risk of developing laryngeal and pharyngeal cancers. There was a considerable heterogeneity between the studies of pharyngeal cancer, but this was mostly due to two studies. The increased risk of laryngeal and pharyngeal cancers caused by alcohol was reversible; the time periods until the risks became equal to those of never drinkers were 36 (95% CI 11–106) and 39 (95% CI 13–103) years, respectively. Moreover, 5 years of drinking cessation was associated with a reduction of around 15% in the alcohol-related elevated risk of laryngeal and pharyngeal cancers. Although a long time period is required to completely eliminate the alcohol-related elevated risk of laryngeal and pharyngeal cancers, a substantial risk reduction can be seen in the short term (5–10 years), and drinking cessation should therefore be encouraged to reduce the incidence of these cancers.


19 September 2020 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
ERElisabet Rodby-Bousquet
Elisabet Rodby-Bousquet
Ann Alriksson-SchmidtAnn Alriksson-Schmidt
Ann Alriksson-Schmidt
Johan  JarlJohan Jarl
Johan Jarl
Aim: To analyse the prevalence of pain, pain sites, pain severity, and pain interfering with work or daily activities and sleep in adults with cerebral palsy (CP).Method: This was a cross‐sectional study based on data from 1591 adults (16–76y, median age 25y; 879 males, 712 females; Communication Function Classification System [CFCS] levels I–V) in the Swedish Cerebral Palsy Follow‐up Program. Pain severity was rated for several body sites and pain interference with activities/work and sleep was also evaluated. Logistic regression was used to estimate the odds ratios (ORs) of the factors associated with the prevalence of pain and pain interfering with activities/work or sleep.Results: Pain was reported in 1059 of 1591 adults; a higher proportion self‐reported pain (69.9%) compared to proxy‐reported pain (62.4%). More adults classified in CFCS level I (72.5%) reported pain compared to those in CFCS levels II to V (56.5–64.9%). Adults with severe/very severe pain had a sixfold risk of pain interfering with activity/work (OR=6.68; 95% CI 4.99–8.96) and sleep (OR=6.60; 95% CI 4.84–8.98).Interpretation: Two‐thirds of adults with CP experienced pain, which is likely to be underreported in individuals who do not communicate efficiently or rely on proxy reports. Pain strongly interfered with activities and sleep; thus, it must be assessed and treated more effectively.What this paper adds: Two‐thirds of adults with cerebral palsy (CP) experienced pain from a median of three body sites. Pain is likely to be underreported in adults who do not communicate efficiently or rely on proxy reports. Adults with CP in severe pain had a sixfold risk of pain interfering with activity/work and sleep.